PTH and osteoporosis: Nowadays, pharmacological modalities for osteoporosis, such as bisphosphonates, antibodies, parathyroid hormone (PTH)-related peptides, and teriparatide, exhibit limitations in their therapeutic efficacy and are linked with consequential side effects.